Table 3. Clinical outcome.
Liver function improvement (n = 60) | |
|
55 (91.7 %) |
|
5 (8.3 %) |
Total bilirubin (μmol/L) | |
|
202 (30–719) |
|
63.8 (3–323) |
(P < .001) | |
Day 3 bilirubin, (n) | 22/60 (36.7 %) |
|
86 |
Day 7 bilirubin, (n) | 11/60 (18.3 %) |
|
43.5 |
Week 2 bilirubin, (n) | 21/60 (35 %) |
|
46.7 |
Patient mortality | 48/60 (80 %) |
|
177 days |
EUS-BD, endoscopic ultrasound-guided biliary drainage